Ferigatto J, Coracin F, Tanimoto H, Viola V, Tieghi-Neto V, Prado D
Support Care Cancer. 2025; 33(1):69.
PMID: 39755852
DOI: 10.1007/s00520-024-09114-w.
Wang Y, Turkstani H, Alfaifi A, Akintoye S
Diagnostics (Basel). 2024; 14(23).
PMID: 39682583
PMC: 11640485.
DOI: 10.3390/diagnostics14232676.
Weerakkody D, Nguyen K, Lok E, Khor R, Ng S, Starvaggi B
Craniomaxillofac Trauma Reconstr. 2024; :19433875241242940.
PMID: 39553823
PMC: 11563015.
DOI: 10.1177/19433875241242940.
Fritz M, Arianpour K, Liu S, Lamarre E, Genther D, Ciolek P
Otolaryngol Head Neck Surg. 2024; 172(2):406-418.
PMID: 39327863
PMC: 11773448.
DOI: 10.1002/ohn.990.
Kilic Durankus N, Somay E, Bascil S, Senyurek S, Ozturk D, Selek U
Biomol Biomed. 2024; 25(1):240-248.
PMID: 39319853
PMC: 11647266.
DOI: 10.17305/bb.2024.11155.
Radiation effects in head and neck and role of hyperbaric oxygen therapy: An adjunct to management.
Kumar V, Sharma V, Pandey S, Pal U
Natl J Maxillofac Surg. 2024; 15(2):220-227.
PMID: 39234127
PMC: 11371294.
DOI: 10.4103/njms.njms_185_23.
Pre- and Post-Operative Quality of Life in Patients with Osteoradionecrosis of the Jaw.
Otto S, Shreeja S, Kakoschke S, Albittar M, Widenhorn A, Kakoschke T
Cancers (Basel). 2024; 16(12).
PMID: 38927961
PMC: 11201672.
DOI: 10.3390/cancers16122256.
Timing of development of osteoradionecrosis post head and neck radiotherapy: does a safe time interval exist for dental extraction?.
Kovarik P, Cvek J, Patil R, Macdougall C, Kelly C, Jackson M
Strahlenther Onkol. 2024; 200(10):882-894.
PMID: 38918259
DOI: 10.1007/s00066-024-02251-5.
Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.
Watson E, Hueniken K, Lee J, Huang S, El Maghrabi A, Xu W
J Clin Oncol. 2024; 42(16):1922-1933.
PMID: 38691822
PMC: 11500043.
DOI: 10.1200/JCO.23.01951.
International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study.
medRxiv. 2024; .
PMID: 38645105
PMC: 11030490.
DOI: 10.1101/2024.04.07.24305400.
Resemblances and differences between osteoradionecrosis of the jaw and medication-related osteonecrosis of the jaw.
Golu M, Pascanu I, Petrovan C, Mocan S, Cosarca A, Temistocle D
Med Pharm Rep. 2024; 97(1):76-83.
PMID: 38344330
PMC: 10852124.
DOI: 10.15386/mpr-2610.
Oral Complications from Oropharyngeal Cancer Therapy.
Sankar V, Xu Y
Cancers (Basel). 2023; 15(18).
PMID: 37760517
PMC: 10526346.
DOI: 10.3390/cancers15184548.
Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U
Strahlenther Onkol. 2023; 199(10):910-921.
PMID: 37566126
DOI: 10.1007/s00066-023-02119-0.
Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E, Somay E, Yilmaz B, Pehlivan B, Selek U
BMC Cancer. 2023; 23(1):651.
PMID: 37438683
PMC: 10337124.
DOI: 10.1186/s12885-023-11155-z.
Early Second Free Flap is Required in Osteoradionecrosis-related Nonunion after Primary Mandible Reconstruction.
Tee R, Schweizer R, Gomez-Martinez-de-Lecea C, Kildal V, Thor A, Rodriguez-Lorenzo A
Plast Reconstr Surg Glob Open. 2023; 11(6):e5024.
PMID: 37334393
PMC: 10270492.
DOI: 10.1097/GOX.0000000000005024.
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors.
Topkan E, Kucuk A, Somay E, Yilmaz B, Pehlivan B, Selek U
J Clin Med. 2023; 12(8).
PMID: 37109361
PMC: 10143049.
DOI: 10.3390/jcm12083025.
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U
BMC Oral Health. 2023; 23(1):231.
PMID: 37081475
PMC: 10116666.
DOI: 10.1186/s12903-023-02937-9.
Comment on: Risk factors for osteoradionecrosis of the jaw in patients with oral or oropharyngeal cancer: Verification of the effect of tooth extraction before radiotherapy using propensity score matching analysis.
Yilmaz B, Somay E, Topkan E
J Dent Sci. 2023; 18(2):919-920.
PMID: 37021243
PMC: 10068363.
DOI: 10.1016/j.jds.2022.10.010.
Osteoradionecrosis of the Jaw-Comparison between Bone and Soft Tissue Injury and Their Influence on Surgical Outcomes-A Retrospective Cohort Study.
Ristow O, Birgel J, Ruckschloss T, Held T, Lang K, Smielowski M
Diagnostics (Basel). 2023; 13(3).
PMID: 36766471
PMC: 9914009.
DOI: 10.3390/diagnostics13030366.
Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
Yilmaz B, Somay E, Topkan E, Pehlivan B, Selek U
Eur Arch Otorhinolaryngol. 2023; 280(5):2575-2584.
PMID: 36749372
DOI: 10.1007/s00405-023-07864-7.